Sanofi Announces $20 Billion US Investment Plan Through 2030
French pharmaceutical giant Sanofi has committed to investing at least $20 billion in the United States by 2030, according to a Wednesday announcement. The funds will target expanded R&D capabilities and domestic manufacturing infrastructure.
The company’s 13,000 US employees currently lead development of first-in-class therapeutics across multiple disease areas. This planned capital injection aims to secure local production of critical medications as Sanofi prepares for potential launches of novel treatments.
Log in to Reply
Log in to comment your thoughtsComments
Related Articles
|Square
Get the BTCC app to start your crypto journey
Get started today Scan to join our 100M+ users